Our current study revealed that loss of CLCA2 protein expression was a poor prognostic factor in female patients with lung SCC, indicating that the CLCA2 expression status is associated with a poor prognosis, not only in patients with breast cancer but also in those with SCC of the lung. Here, CLCA2 is linked to breast cancer.